0,899  0,002  Ulceration
0,833  0,003  Cardiodepressant
0,782  0,005  CYP2D6 substrate
0,750  0,005  Vasodilator, peripheral
0,729  0,003  Cyclic AMP phosphodiesterase inhibitor
0,699  0,018  CYP3A4 substrate
0,607  0,005  Sedative
0,583  0,005  P-glycoprotein inhibitor
0,609  0,033  Antineoplastic (breast cancer)
0,596  0,031  Antineoplastic (lung cancer)
0,575  0,026  Antineoplastic (colorectal cancer)
0,568  0,025  Antineoplastic (colon cancer)
0,541  0,008  Psychostimulant
0,519  0,004  Alpha 2 adrenoreceptor antagonist
0,519  0,005  Alpha adrenoreceptor antagonist
0,496  0,006  Antihypotensive
0,478  0,004  Alpha 2c adrenoreceptor antagonist
0,463  0,029  Spasmolytic
0,504  0,073  Apoptosis agonist
0,434  0,019  Antimitotic
0,443  0,036  Antineoplastic (ovarian cancer)
0,409  0,010  Antineoplastic (squamous cell carcinoma)
0,404  0,016  Anesthetic general
0,391  0,009  Antiadrenergic
0,382  0,005  Alpha 2b adrenoreceptor antagonist
0,382  0,006  Acetylcholine M1 receptor antagonist
0,429  0,055  Antileukemic
0,409  0,037  ICAM1 expression inhibitor
0,382  0,012  Male reproductive disfunction treatment
0,386  0,026  Vasodilator
0,405  0,051  Prostate cancer treatment
0,354  0,010  Erectile dysfunction treatment
0,375  0,035  Calcium channel activator
0,377  0,041  CYP2D6 inhibitor
0,346  0,010  Acetylcholine antagonist
0,379  0,047  Antihypertensive
0,342  0,011  Cholinergic antagonist
0,406  0,077  Calcium channel L-type activator
0,389  0,066  Transcription factor NF kappa B inhibitor
0,327  0,005  ATPase inhibitor
0,377  0,060  Antiprotozoal (Plasmodium)
0,360  0,050  NOS3 expression inhibitor
0,377  0,078  Antiprotozoal
0,309  0,010  Alpha 1 adrenoreceptor antagonist
0,309  0,013  Adrenaline antagonist
0,300  0,004  Raynaud's phenomenon treatment
0,304  0,008  Nav1.1 sodium channel blocker
0,289  0,007  Alpha 2a adrenoreceptor antagonist
0,327  0,046  Antiprotozoal (Leishmania)
0,285  0,007  Age-related macular degeneration treatment
0,298  0,022  Antineoplastic (carcinoma)
0,274  0,007  Nav1.6 sodium channel blocker
0,318  0,053  Antineoplastic (cervical cancer)
0,275  0,011  Nav1.3 sodium channel blocker
0,301  0,052  Platelet antagonist
0,287  0,046  Dependence treatment
0,254  0,014  Acetylcholine muscarinic antagonist
0,240  0,004  Antiprotozoal activity enhancer
0,331  0,097  Immunosuppressant
0,251  0,028  Cholinergic
0,224  0,008  Antineoplastic alkaloid
0,229  0,013  Alpha 1a adrenoreceptor antagonist
0,258  0,048  Platelet aggregation inhibitor
0,231  0,024  VEGF expression inhibitor
0,211  0,005  Acetylcholine M4 receptor antagonist
0,265  0,072  Teratogen
0,253  0,061  Cytotoxic
0,209  0,028  Antifungal enhancer
0,251  0,071  Antineoplastic (liver cancer)
0,280  0,103  Antithrombotic
0,210  0,034  Tubulin antagonist
0,243  0,073  Angiogenesis stimulant
0,242  0,075  Antineoplastic (sarcoma)
0,275  0,110  Vasodilator, coronary
0,184  0,024  Microtubule formation inhibitor
0,251  0,093  Antineoplastic (melanoma)
0,239  0,081  Antidiabetic symptomatic
0,158  0,003  Vesicle monoamine transporter inhibitor
0,274  0,128  CYP2C9 substrate
0,183  0,037  Cocaine dependence treatment
0,161  0,020  Alpha 1b adrenoreceptor antagonist
0,182  0,041  Nav1.2 sodium channel blocker
0,148  0,008  Glycine receptor antagonist
0,205  0,066  Nitric oxide antagonist
0,245  0,106  Anxiolytic
0,175  0,039  Psychosexual dysfunction treatment
0,151  0,019  Acetylcholine M3 receptor agonist
0,202  0,070  Platelet adhesion inhibitor
0,234  0,103  Antineoplastic (pancreatic cancer)
0,185  0,055  Prostate disorders treatment
0,171  0,043  Neurotrophic factor
0,273  0,148  15-Lipoxygenase inhibitor
0,251  0,127  Sodium/bile acid cotransporter inhibitor
0,129  0,008  Dopamine transporter inhibitor
0,131  0,016  Phosphodiesterase 11A inhibitor
0,131  0,016  Phosphodiesterase XI inhibitor
0,203  0,090  Embryotoxic
0,166  0,054  Anesthetic
0,201  0,093  Antineoplastic (lymphoma)
0,178  0,072  Chemopreventive
0,145  0,039  Antineoplastic (uterine cancer)
0,220  0,115  Cardioprotectant
0,156  0,052  MAP3K9 inhibitor
0,215  0,112  Antipsychotic
0,201  0,099  Antineoplastic (glioma)
0,144  0,043  5 Hydroxytryptamine 2B antagonist
0,230  0,133  AR expression inhibitor
0,258  0,161  Antineoplastic (myeloid leukemia)
0,130  0,033  Acetylcholine agonist
0,173  0,077  Antineoplastic (gastric cancer)
0,109  0,016  Dopamine uptake inhibitor
0,189  0,097  Antiulcerative
0,168  0,077  Macular degeneration treatment
0,113  0,022  5 Hydroxytryptamine uptake inhibitor
0,245  0,157  Antineoplastic (endocrine cancer)
0,185  0,101  Antineoplastic enhancer
0,180  0,097  Antineoplastic (glioblastoma multiforme)
0,161  0,079  Prostatic (benign) hyperplasia treatment
0,136  0,057  DNA polymerase I inhibitor
0,101  0,023  Alpha 1d adrenoreceptor antagonist
0,225  0,152  Apoptosis antagonist
0,163  0,090  Diabetic retinopathy treatment
0,091  0,019  Protein kinase C eta inhibitor
0,105  0,036  Acetylcholine nicotinic antagonist
0,088  0,020  Alpha 1 adrenoreceptor agonist
0,234  0,169  Antineoplastic (small cell lung cancer)
0,187  0,122  Vascular (periferal) disease treatment
0,097  0,034  Nicotinic alpha4beta2 receptor antagonist
0,075  0,015  Nicotinic alpha3beta2 receptor antagonist
0,089  0,031  Calcium channel L-type blocker
0,099  0,041  ATPase (Vacuolar H+) inhibitor
0,074  0,017  Acetylcholine M2 receptor agonist
0,083  0,027  Acetylcholine M2 receptor antagonist
0,089  0,033  Phosphodiesterase V inhibitor
0,105  0,051  Breast cancer-resistant protein inhibitor
0,173  0,121  Free radical scavenger
0,179  0,127  Antineoplastic (renal cancer)
0,199  0,149  Antifungal
0,085  0,039  Narcotic antagonist
0,072  0,026  Acetylcholine muscarinic agonist
0,082  0,036  Prokinetic
0,173  0,128  Antineoplastic (non-small cell lung cancer)
0,151  0,109  Hepatoprotectant
0,172  0,131  Cytostatic
0,079  0,040  Phosphodiesterase 5A inhibitor
0,071  0,033  Adrenaline uptake inhibitor
0,120  0,082  Phosphodiesterase inhibitor
0,095  0,058  Alpha 2d adrenoreceptor antagonist
0,202  0,167  Angiogenesis inhibitor
0,068  0,033  Acetylcholine M3 receptor antagonist
0,102  0,068  Topoisomerase I inhibitor
0,084  0,054  Antineoplastic antibiotic
0,200  0,172  CYP3A4 inhibitor
0,061  0,041  Acetylcholine M5 receptor antagonist
0,036  0,016  Protein kinase C beta I inhibitor
0,052  0,034  Glucose-6-phosphate translocase inhibitor
0,053  0,037  Alpha tubulin antagonist
0,253  0,236  Antineoplastic (solid tumors)
0,043  0,026  Factor XIa inhibitor
0,078  0,062  Opioid kappa receptor antagonist
0,044  0,029  Opioid kappa receptor agonist
0,087  0,073  Butyrylcholinesterase inhibitor
0,055  0,041  Peristaltic stimulant
0,167  0,156  Cardiotonic
0,136  0,128  Lipocortins synthesis antagonist
0,136  0,128  Antimigraine
0,079  0,071  Opioid antagonist
0,182  0,175  Hepatic disorders treatment
0,044  0,042  Phosphodiesterase 6C inhibitor
0,081  0,079  Protein kinase C mu inhibitor
0,187  0,185  Antineoplastic (brain cancer)
0,030  0,029  Protein kinase C beta II inhibitor
0,041  0,040  Microtubule stabilization

